Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-29 Purchase | 2021-12-01 11:06 am | Eloxx Pharmaceuticals Inc. | ELOX | Geffken Daniel E. CFO | 50,000 | $0.72 | $36,000 | 50,000 (Direct) | View |
| 2021-05-13 Purchase | 2021-05-17 09:22 am | Eloxx Pharmaceuticals Inc. | ELOX | PAREKH RAJESH B Director | 2,466,666 | $1.35 | $3,329,999 | 4,827,129 (Indirect) | View |
| 2021-05-13 Purchase | 2021-05-17 07:03 am | Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (China) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (Israel) IV L.P. Pontifax IV GP L.P. 10% Owner | 5,925,925 | $1.35 | $7,999,999 | 616,592 (Indirect) | View |
| 2021-05-13 Purchase | 2021-05-17 07:02 am | Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director | 5,925,925 | $1.35 | $7,999,999 | 7,804,778 (Indirect) | View |
| 2021-05-13 Purchase | 2021-05-17 07:00 am | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 5,925,925 | $1.35 | $7,999,999 | 7,804,778 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-12-01 Exercise | 2021-12-03 5:16 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Walts Alan Edmund Director | 37,695 | $0 | 37,695 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-03 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit CEO | 279,158 | $0 | 197,225 (Direct) | View |
| 2021-12-01 Tax Withholding | 2021-12-03 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit CEO | 81,933 | $0.72 | 197,225 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-03 5:14 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R & D | 219,326 | $0 | 154,953 (Direct) | View |
| 2021-12-01 Tax Withholding | 2021-12-03 5:14 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R & D | 64,373 | $0.72 | 154,953 (Direct) | View |
| 2021-07-30 Exercise | 2021-07-30 8:32 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,563 | $0 | 42,074 (Direct) | View |
| 2021-07-30 Tax Withholding | 2021-07-30 8:32 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 459 | $1.32 | 42,074 (Direct) | View |
| 2021-05-25 Tax Withholding | 2021-05-26 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,835 | $1.39 | 100,345 (Direct) | View |
| 2021-05-25 Exercise | 2021-05-26 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 6,250 | $0 | 100,345 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:11 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Walts Alan Edmund Director | 3,334 | $0 | 3,334 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:11 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | PAREKH RAJESH B Director | 3,334 | $0 | 3,334 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:10 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Avnur Zafrira Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:10 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:10 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:10 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Veinrib Gadi Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:10 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Rubin Steven D Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:10 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-18 5:48 pm | N/A 2031-04-01 | Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R & D | 496,204 | $0 | 496,204 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-18 5:45 pm | N/A 2031-04-01 | Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit CEO | 992,409 | $0 | 992,409 (Direct) | View |
| 2021-04-30 Exercise | 2021-05-03 10:15 am | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,562 | $0 | 38,118 (Direct) | View |
| 2021-04-30 Tax Withholding | 2021-05-03 10:15 am | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 459 | $2.18 | 38,118 (Direct) | View |
| 2021-04-20 Option Award | 2021-04-22 11:55 am | N/A 2026-04-20 | Eloxx Pharmaceuticals Inc. | ELOX | Geffken Daniel E. CFO | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-05 8:33 pm | N/A 2031-04-01 | Eloxx Pharmaceuticals Inc. | ELOX | PAREKH RAJESH B Director | 2,572,270 | $0 | 2,485,239 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 9:04 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Walts Alan Edmund Director | 77,695 | $0 | 77,695 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 9:00 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R & D | 930,945 | $0 | 1,105,588 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 8:55 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit CEO | 1,702,396 | $0 | 1,925,700 (Direct) | View |
| 2021-03-24 Ownership | 2021-03-26 8:50 pm | N/A 2030-01-21 | Eloxx Pharmaceuticals Inc. | ELOX | Rakers Gary D. Controller PFO/PAO Treasurer | 0 | $0 | 42,225 (Direct) | View |
| 2021-02-25 Tax Withholding | 2021-02-26 7:05 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 7,338 | $3.95 | 101,077 (Direct) | View |
| 2021-02-25 Exercise | 2021-02-26 7:05 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 25,000 | $0 | 101,077 (Direct) | View |
| 2021-02-25 Tax Withholding | 2021-02-26 7:05 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 15,360 | $3.95 | 194,629 (Direct) | View |
| 2021-02-25 Exercise | 2021-02-26 7:05 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 50,000 | $0 | 194,629 (Direct) | View |
| 2021-02-12 Option Award | 2021-02-17 6:43 pm | N/A 2031-02-12 | Eloxx Pharmaceuticals Inc. | ELOX | MacDonald Stephen G. VP | 18,849 | $0 | 18,849 (Direct) | View |
| 2021-02-12 Option Award | 2021-02-17 6:40 pm | N/A 2031-02-12 | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-02-12 Option Award | 2021-02-17 6:38 pm | N/A 2031-02-12 | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2021-01-30 Tax Withholding | 2021-02-02 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 542 | $3.44 | 20,915 (Direct) | View |
| 2021-01-30 Exercise | 2021-02-02 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,563 | $0 | 20,915 (Direct) | View |
| 2021-01-30 Tax Withholding | 2021-02-02 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 643 | $3.44 | 24,989 (Direct) | View |
| 2021-01-30 Exercise | 2021-02-02 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 1,875 | $0 | 24,989 (Direct) | View |
| 2020-02-24 Ownership | 2021-01-22 4:05 pm | N/A 2029-10-21 | Eloxx Pharmaceuticals Inc. | ELOX | MacDonald Stephen G. VP | 0 | $0 | 56,600 (Direct) | View |